What is Cystic Fibrosis?
Cystic fibrosis (CF) is the most common, life threatening inherited disease amongst the Caucasian population.
There are an estimated 100,000 sufferers worldwide and 1 in 2500 live births of children with cystic fibrosis. It is the mission of CFW to reach out to these countries by working to help develop effective CF clinical care. This includes helping to organize much needed medications, development, training and education of health care providers and spreading awareness of CF at the government and community levels. It is our objective to find a solution that will bring long-term benefits to the existing people with CF and to those patients who will be born in the future. Until a cure is found, we will strive to provide humane situations for those who are currently suffering from an inhumane disease globally. 
President's Report
It is pleasing to be able to write this report on the first year's operations of Cystic Fibrosis Worldwide. Over the past year we have faced a number of challenges in beginning to provide a new identity and path for CFW which was formed through the merger of ICF(M)A and IACFA.
The merge of the two organisations has taken a lot of effort as, while we share a common goal of making life better for those whose lives are affected by CF, the organisations had different histories and cultures. It is a tribute to the strength of the new organisation and the good will of those who were involved with both organisations that CFW has developed new contacts and project areas.
We recognised that CFW needed to have a solid foundation and the Board made the choice to invest in recruiting staff to work on the day-to-day issues and development of the organization. Our major focus is on helping support countries where cystic fibrosis care is not available in any sustained/developed way. Our project manager Christine Noke has taken the initiative for several projects, among them the project to develop a cystic fibrosis clinic in Tbilisi, Georgia and the Burke Bear campaign. With these projects CFW is seeking to develop a system that can be replicated and used in other countries to develop basic clinical care for CF.
One of the other positive changes we have made is to consolidate the financial matters as part of the duties of our Office Manager, Gina Steenkamer. The treasurer still has overall control of the organisation's finances, with the record keeping and transactions managed through our office in The Netherlands. This has enabled us to improve our administrative and control systems.
It is imperative for the new organisation to recruit dedicated and committed people to continue its development. In this context it becomes increasingly important for those who seek a position on the Board to bring their skills and energy to developing new funding and providing good governance. We have been lucky to have a Board made up of people who have taken the CF cause to heart and seen us this far. It is now important that both they and any new volunteers work even harder to guide us in the future.
CFW has become an essential factor in bringing national associations from all over the world together to work on an international scale to improve the lives of those affected by CF. To do this we need to continue to receive the invaluable help of the many people who support our cause, our members, CF clinicians, health care professionals, corporations and governments worldwide.
I look forward to travelling with you on our journey.
Herman Weggen President
The Project to bring change
We begin our campaign with the 'The Republic of Georgia,' of the former Soviet Union, and the CF Charity Foundation of Georgia (CFG) in Tbilisi, as our Pilot Project. CFW and the CFG will work in collaboration to develop sustainable advancements in the delivery of clinical care, access to medication and the spread of education in the treatment of CF in Georgia and surrounding regions.
The situation in CF related care today in Georgia leaves CF patients with no CF clinical care or delayed service at best and very rarely at the beginning stage. Most people with CF are forced to try to seek care in foreign countries at great financial and moral expense to their families. There are no training facilities for medical staff, among parents, teachers and nurses of the patients. The basic antibiotics and pancreatic enzymes that most CF patients rely on daily are nonexistent for people with CF in Georgia. While the average life expectancy in developing countries has moved to beyond 32 years, in Georgia the average life expectancy for CF patients is only 16.
The project will be completed through a series of five phases.
PHASE I: RENOVATION AND IMPLEMENTATION

March 2004
• An existing empty wing of the Children's Central Hospital has been renovated to create 10 patient rooms, a physiotherapy center and diagnostic laboratory equipped with basic start-up equipment and supplies. Amount secured: $93,000
PHASE II: EDUCATION AND EVALUATION
November 2004
• CFW will send a group of CF Specialized clinicians to Georgia to train the future clinic staff and evaluate patient needs.
• A database will be created to build the Georgian National CF Registry.
• A Process Evaluation will be done to determine effective import and distribution methods in the delivery of free medication.
• Manuals will be created from appropriate educational sources offered free at the Georgian National CF Center in the national language.
PHASE III: DIAGNOSTIC IMPLEMENTATION
January 2005
• Using the data provided by the CF specialized team in Phase II, CFW will equip the laboratory and train a technician in diagnostic procedures and optimal microbiology.
PHASE IV: MEDICATION AND ADAPTATION
June 2005
• CFW will negotiate access to necessary medications and technical equipment through established networks among suppliers and Pharmaceutical organizations.
• An "outreach" program will be established by means of creating a mobile clinic and dispensary operated by the existing trained specialists (phase II) to travel throughout Georgia. Collection for diagnostic determinations will be available as well educational information and supplies to fill prescriptions of the diagnosed patients.
• CFW and the CFG will host the first annual educational seminar in Tbilisi with both lay and medical topics being covered. Local media, brochures and clinical staff will advertise this conference.
PHASE V: SUSTAINABILITY
January 2006
• CFW will send marketing specialists (2) to educate the CF Foundation of Georgia on current philanthropic methods such as grant writing, hosting events and building corporate partnering programs. CFW will work with the World Health Organization to continue to educate the Georgian government on the need to support those who suffer from CF in Georgia.
To track the effects this program has on people with CF and those who live and care for them, CFW and the University of Maastricht will perform an outcomes evaluation beginning May 1, 2004.
What is the outcome?
Outcomes are benefits to clients who utilize the clinic, free medication and information Centre being developed in the Republic of Georgia. The evaluation will also include effects on families, the Children's Central Hospital and the communities where people with CF live. Outcomes should not be confused with program outputs or units of services, e.g. the number of clients who visit the clinic each month but instead focus on how the lives of those who do visit have changed. The managing medical staff operating the Georgian CF Centre will also benefit from an outcomes evaluation that will tease out and define program strengths and weaknesses.
In developing health care systems there is a need to build capacity for the management of chronic disease such as CF from both health care and patient/family perspectives to the needs of developing countries social and health care systems. Cystic Fibrosis is a genetic disease with a full range of chronic disease management components representing the demands on family, health care systems, governments, communities and international resources when implementing management models.
This program has two primary objectives. First the outcomes evaluation is to provide regular, systematic tracking of the extent to which program participants experience the benefits of changes intended. By successfully tracking the impact our program has on the people with CF, CFW will communicate value and increase effectiveness for improving quantity and quality of life for people with CF globally.
The second primary objective is to develop healthcare infrastructure for the management of CF in the Republic of Georgia and to disseminate the development plan to both other chronic diseases and other developing countries. The PhD student at the University of Maastricht Department of Health and Education and Health Promotion will base her work on the evaluation of the Georgian National CF Centre pilot project being conducted by CF Worldwide.
To achieve these objectives, the University of Maastricht and CFW have put together an evaluation team including members from the CF Association in the Republic of Georgia, CFW board members and Project Manager, University of Maastricht Faculty and a PhD student. The PhD student is skilled in working in underprivileged countries and interested in developing further skills in program evaluation, capacity enhancement and models of chronic disease management.
The team will:
1. Evaluate the program process and outcomes of the Georgian Cystic Fibrosis Centre Pilot Project.
Develop a capacity building and evaluation framework/manual for use by Cystic Fibrosis
Worldwide for the development and evaluation of cystic fibrosis management programs in developing countries.
3. Implement the capacity building and evaluation framework in two additional cystic fibrosis projects in Latin America and the Middle East.
Analyze the lessons learned from the Cystic Fibrosis Worldwide evaluation.
The evaluation capacity building program will begin April 1, 2004 and is scheduled to be completed by April 1, 2008.
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Cystic Fibrosis Worldwide and the University of Maastricht will work in collaboration to evaluate project development for improved treatment in cystic fibrosis management in developing countries.
Press Release 2004
Opening lines of communication...
CFW Website
CFW Forums
In February 2003, CFW was awarded an unrestricted educational grant from Solvay Pharmaceuticals to develop forums on our website that allow for the exchange of information internationally. These forums are moderated by a group of international specialists working in the field of CF from countries like the UK, US and Canada.
The goal of the CFW forums is to create a medium for medical professionals, caregivers and people with CF to ask questions, find answers and build a platform for the exchange of information on an international level. These forums offer multi-language translation and we encourage all nationalities and age groups to utilize this resource.
CFW Library
The CFW online library allows user to search articles from editions of IACFA and CFW newsletters. The Levy Lecture, IPG/CF manual, annual reports and WHO guidelines are also available all searchable by title, author, subject with some articles translated into 6 languages!
CFW and our member associations
Cystic Fibrosis Worldwide is dedicated to promoting the development of CF lay organizations in underdeveloped parts of the world and to promoting the advancement of CF knowledge among medical / scientific and allied health professionals. We offer links to all our member countries and post the latest news and updates from around the world. For more information on joining the CFW's growing member country list contact us at info@cfww.org.
CFW also hosts the International Physiotherapy Group for CF (IPG/CF) and the new CF Europe web pages.
Visit us online at www.cfww.org
CFW Newsletter
The CFW newsletter is offered in print (English) and on our website in several languages. The aim of the CFW newsletter is to circulate information pertaining to CF and to create a platform for the exchange of information globally. The CFW newsletter is distributed to 62 countries and over 4,000 readers worldwide. CFW is expanding this number even further by making the newsletter much more accessible via the Internet. CFW publishes all newsletters online in languages such as English, Spanish, Bulgarian, Georgian, Portuguese and Arabic.
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"The presentation of your website is excellent and your articles are of great value and keep us from getting discouraged."
Dr. Miguel Angel Melendez, Costa Rica
Education
Grants and Scholarships
Cystic Fibrosis Worldwide offers grants to initiatives and educational programs for work related to cystic fibrosis. The deadline for request is March 1 and September 1 annually.
These grants are awarded to individuals who are working in CF communities to improve the health care provided to people with CF.
In 2003 CFW approved grants to Dr. Gabriela Sabolova from the Slovak Republic to study dietary recommendations for individuals with CF and doctors in Uruguay, Hungary and Brazil to study pharmacological treatments and develop research projects.
The grants available:
1. Scholarships These will be for individuals working in the field of clinical CF care wishing to improve their knowledge in a recognized CF centre worldwide.
Visiting Experts
These will be for highly qualified CF experts in order to facilitate their travel and sojourn in CF centres wishing to improve their clinical or scientific expertise.
Research projects
These will be for internationally relevant projects of a globally applicable nature.
Training courses for allied health professional
These grants will cover costs for courses both in the applicant's country and abroad.
Reports from applicants can be obtained through our office at info@cfww.org.
Conferences
In 
Solidarity Fund
Together with the financial support of the National CF associations, CFW has developed a solidarity fund.
This fund will be used to enable people from developing countries representing CF patient associations and patient groups, to attend the 27th European Cystic Fibrosis Conference in Birmingham in June 2004.
Birmingham will be the pilot project, but it is our intention to provide the solidarity fund for future conferences on an annual basis.
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"On behalf of all Slovak CF patients, thank you very much for the opportunity to gain experience, knowledge and encouragement from all the staff at Götenborg CF Centre."
Dr. Gabriela Sabolova, Slovak Republic
Fundraising Burke Bear
Each year on April 7th, the world celebrates World Health Day. On this day around the globe, thousands of events mark the importance of health for productive and happy lives. In 2003, the theme for World Health Day was "Healthy Environments for Children." CFW took this opportunity to launch the Burke Bear Campaign.
In order to fund projects globally, we are reaching out to individuals, corporations and friends of the CF community asking that they join us in bringing Burke to the world to create an international campaign that positively affects those who suffer with CF globally.
Burke P. Bear was named after an incredibly spirited young man, Burke Derr, who died of Cystic Fibrosis (CF) just two days before his 19th birthday. Although his family in the USA miss Burke terribly, they believe his spirit and legacy live on in this Boyd's Limited Edition© Teddy Bear. Burke has now joined forces with CFW in order to continue to fulfill the dream of a young man who wished to help all who suffer with CF world wide.
For more information about the Burke Bear Campaign, please visit www.cfww.org or contact burke@cfww.org.
CFW Celebrity Golf Tournament in Memory of Rick Weggen
Herman Weggen, President of CFW, is a member of the Heerensocieteit van Etten tot Leur, a gentlemen's society that has been in existence for several years in the Netherlands. This very enthusiastic group gathered support through friends, associates and worked with a Dutch organization, Charity and Sport, to organize a golf tournament on October 3, 2003.
A team of 3 people acted as the organizing committee for the Golf Tournament, Frans Heyblom (a real estate agent), Gerard Hogeman (CEO of a theatre) and Herman Weggen (CEO of Avoord).
Thirteen flights were sold to local businesses. Each flight had a special Dutch celebrity as their leader. At the end of this day, an appreciation-dinner was organized. During this dinner the Project Manager, Christine Noke, explained the regional and clinical situation in Georgia and Dr. Harry Heijerman gave a short speech explaining Cystic Fibrosis. Euro 20,000 was raised during this daylong event.
The Heerensocieteit donated all the money raised to CFW for Phase I: Renovation and Implementation.
The Heerensocieteit has agreed to continue to support CFW by holding an annual CFW Celebrity Golf Tournament in Etten Leur. 
Member Countries
CFW proudly lists our many member countries and associate members.
Corporate Sponsors
CFW has developed relationships with our corporate sponsors that will allow us to work towards fulfilling our mission. Our corporate funders share the same vision as CFW and our member countries. That vision is a world where all people who suffer from CF have access to clinical care, medication and information in the treatment of CF no matter where they live.
ICCO and Wilde Ganzen recently awarded euro 40,000 to begin construction on the Georgian National CF Centre. ICCO and Wilde Ganzen have a strategic alliance and both organizations try to provide finances and expertise for projects and programmes that stimulates people to create a just and safe living environment for themselves and others.
Van Aarle De Laat Health Sector Construction
Management Services donate all office facilities and part of the salary of the office administrator. This generous donation allows us to perform as a more professional organized constitution. Van Aarle De Laat will continue to support our administrative costs for the Netherlands CFW office through 2004.
Solvay Pharmaceutical recently awarded CFW with an unrestricted educational grant for the development of the Gastroenterology/Nutrition forums on our website. Solvay has also contributed to the CFW newsletter and offered support to CFW in our efforts to put Pancreatic Enzyme on the WHO essential drug list. Solvay's contributions have made it possible for the CFW to carry out our mission of creating a platform for the exchange of information worldwide.
Micronics Inc. is our newest corporate sponsor providing travel expenses for fundraising and administrative costs. We look forward to future fundraising activities with Micronics Inc.
If you would like to learn more about our sponsors and member countries, please visit our website at www.cfww.org. If you are interested in obtaining information about becoming a sponsor or applying for membership email us at info@cfww.org ...because together we can make a difference.
